2022 WMIF | The Dr. Is In | The Inner Workings of Gene Therapy Manufacturing

The Inner Workings of Gene Therapy Manufacturing In this session, Dr. Nikiforow will provide insights into the world of gene therapy manufacturing and the complexities of scaling, costs and insurance reimbursement. Michael Ryskin, Director, Global Research, BofA Securities Sarah Nikiforow, MD, PhD, Medical Director, Cell Manipulation Core Facility, Technical Director, Immune Effector Cell Therapy Program, DFCI; Assistant Professor, HMS